BBLG
Bone Biologics Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.22
-0.04 ▼ -3.17%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$1.25
+0.03 ▲ +2.46%
| Index | - | P/E | - | EPS (ttm) | -4 | Insider Own | 0.04% | Shs Outstand | 0.00B | Perf Week | -4.69% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 16.06% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -6.15% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.54 | Inst Own | 2.84% | Short Float | 1.7% | Perf Quarter | -41.77% |
| Income | -0.00B | P/S | - | EPS this Y | 27.17% | Inst Trans | 2.26% | Short Ratio | 0.1 | Perf Half Y | -42.18% |
| Sales | 0.00B | P/B | 0.41 | EPS next 5Y | - | ROA | -64.38% | Short Interest | 0.03M | Perf YTD | -15.86% |
| Book/sh | 3 | P/C | 0.41 | EPS past 3/5Y | 75.82% 68.85% | ROE | -70.17% | 52W High | -81.93% ($6.75) | Perf Year | -75.42% |
| Cash/sh | 2.97 | P/FCF | - | Sales past 3/5Y | - | ROIC | -57.81% | 52W Low | 9.91% ($1.11) | Perf 3Y | -99.64% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.31% | Gross Margin | - | Volatility(W/M) | 4.91% 6.5% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.85 | EPS Q/Q | 87.66% | Profit Margin | - | RSI (14) | 42.12 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.85 | Sales Q/Q | - | SMA20 | 1.04% ($1.21) | Beta | 0.7 | Target Price | $22.2 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | -14.64% ($1.43) | Rel Volume | 0.05 | Prev Close | $1.26 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -70.59% - | SMA200 | -48.59% ($2.37) | Avg Volume(3M) | 0.31M | Price | $1.22 |
| IPO | 2016/3/31 | Option/Short | No/Yes | Trades | 70 | Volume | 14,681 | Change | -3.17% |
뉴스 로딩 중...